[Antitumor effect of Corynebacterium parvum and poly ICLC on experimental brain tumors].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D001932:Brain Neoplasms / Q000139:chemically induced / Q000628:therapy*; D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use* / Q000031:analogs & derivatives; D005910:Glioma / Q000139:chemically induced / Q000628:therapy*; D007369:Interferon Inducers / Q000627:therapeutic use*; D008747:Methylcellulose / Q000031:analogs & derivatives*; D008748:Methylcholanthrene; D051379:Mice; D008810:Mice, Inbred C57BL; D010455:Peptides / Q000627:therapeutic use*; D011070:Poly I-C / Q000627:therapeutic use*; D011107:Polylysine / Q000627:therapeutic use* / Q000031:analogs & derivatives; D011425:Propionibacterium acnes / Q000276:immunology*
D000276:Adjuvants, Immunologic; D007369:Interferon Inducers; D010455:Peptides; D011107:Polylysine; D008748:Methylcholanthrene; C019531:poly ICLC; D008747:Methylcellulose; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C